ERNA · Ernexa Therapeutics Inc. · Documents
$1.97
-0.03 (-1.38%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“As of June 30, 2026, the Company had approximately $5.0 million in cash, which is less than that needed to effect its current operating plan and forecasted cash requirements for the next twelve months. However, management expects that its ability to access capital under its ATM will cover shortfalls in its cash resources over the next twelve months from the issuance date of these financial statements.”View the 10-Q filed Aug 6, 2026
Market Cap
$3.25M
Shares
1.63M
Volume · Oct 28
3029
Avg daily vol (3M)
51.78K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-07-19 | 2021-07-13 | |
| 8-K | — | 2021-07-19 | 2021-07-16 | |
| DEFA14A | — | 2021-07-01 | — | |
| DEF 14A | — | 2021-07-01 | 2021-08-20 | |
| PRE 14A | — | 2021-06-21 | 2021-08-20 | |
| 8-K | — | 2021-06-21 | 2021-06-16 | |
| 8-K | — | 2021-06-14 | 2021-06-13 | |
| 8-K | — | 2021-06-10 | 2021-06-05 | |
| S-1 | — | 2021-05-27 | — | |
| 8-K | — | 2021-05-26 | 2021-05-20 | |
| 10-Q | — | 2021-05-17 | 2021-03-31 | |
| 8-K | — | 2021-05-11 | 2021-05-06 | |
| 8-K | — | 2021-04-30 | 2021-04-26 | |
| 8-K/A | — | 2021-04-30 | 2021-03-25 | |
| S-1 | — | 2021-04-30 | — | |
| 8-K | — | 2021-04-23 | 2021-04-21 | |
| 8-K | — | 2021-04-16 | 2021-04-12 | |
| 8-K | — | 2021-04-15 | 2021-04-09 | |
| 8-K | — | 2021-04-07 | 2021-04-01 | |
| 8-K | — | 2021-03-31 | 2021-03-25 | |
| 8-K | — | 2021-03-23 | — | |
| 8-K | — | 2021-03-16 | 2021-03-15 | |
| 10-K | — | 2021-03-11 | 2020-12-31 | |
| 8-K | — | 2021-03-08 | — | |
| 8-K | — | 2021-02-26 | — | |
| 8-K | — | 2021-02-25 | — | |
| 8-K | — | 2021-02-09 | — | |
| 8-K | — | 2021-02-04 | 2021-02-03 | |
| S-4/A | — | 2021-01-20 | — | |
| 8-K | — | 2021-01-15 | 2021-01-12 | |
| S-4/A | — | 2020-12-22 | — | |
| S-4/A | — | 2020-11-25 | — | |
| 8-K | — | 2020-11-23 | 2020-11-19 | |
| 10-Q | — | 2020-11-13 | 2020-09-30 | |
| 8-K | — | 2020-11-13 | — | |
| 8-K | — | 2020-11-05 | 2020-11-01 | |
| S-4 | — | 2020-10-02 | — | |
| 8-K | — | 2020-09-18 | — | |
| 8-K | — | 2020-08-14 | 2020-08-12 | |
| 8-K | — | 2020-08-13 | — | |
| 8-K | — | 2020-08-12 | — | |
| 8-K | — | 2020-08-07 | — | |
| 10-Q | — | 2020-08-07 | 2020-06-30 | |
| 8-K | — | 2020-07-01 | 2020-06-25 | |
| 8-K | — | 2020-06-17 | 2020-06-12 | |
| 8-K | — | 2020-06-15 | 2020-06-11 | |
| 8-K | — | 2020-06-02 | 2020-05-27 | |
| 10-Q | — | 2020-05-20 | 2020-03-31 | |
| 8-K | — | 2020-05-19 | — | |
| 10-K/A | — | 2020-04-27 | 2019-12-31 |
Showing 151–200 of 206 filings